[Vitiligo: Clinical presentation and pathogenesis].

作者: M. Schild , M. Meurer

DOI: 10.1007/S00105-015-3751-5

关键词:

摘要: Background Vitiligo is a chronic skin disorder with depigmentation of circumscribed areas due to structural and functional damage melanocytes. Results There international consensus on the classification in nonsegmental segmental vitiligo. The influence vitiligo quality life significant influenced by ethnic sociocultural factors. new insight into genetic susceptibility, mechanisms targets autoimmune inflammation, altered morphology function melanocytes association other diseases, cancer therapy. Conclusions recognition associated disorders as important assessment changes life. New pathogenesis may have therapeutic consequences. relationship between immunotherapies patients metastatic melanoma warrants close clinical monitoring affected further scientific studies.

参考文章(80)
K.U. Schallreuter, M.M.A.E.L. Salem, Vitiligo. What is new Hautarzt. ,vol. 61, pp. 578- 585 ,(2010) , 10.1007/S00105-009-1916-9
Ilse Mollet, Nanny van Geel, Jo Lambert, Autoimmune/Inflammatory and Other Diseases Associated with Vitiligo Vitiligo. pp. 79- 90 ,(2010) , 10.1007/978-3-540-69361-1_11
Christian Krüger, Karin Uta Schallreuter, A review of the worldwide prevalence of vitiligo in children/adolescents and adults. International Journal of Dermatology. ,vol. 51, pp. 1206- 1212 ,(2012) , 10.1111/J.1365-4632.2011.05377.X
Yorihisa Kotobuki, Atsushi Tanemura, Lingli Yang, Saori Itoi, Mari Wataya-Kaneda, Hiroyuki Murota, Minoru Fujimoto, Satoshi Serada, Tetsuji Naka, Ichiro Katayama, Dysregulation of melanocyte function by Th17‐related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris Pigment Cell & Melanoma Research. ,vol. 25, pp. 219- 230 ,(2012) , 10.1111/J.1755-148X.2011.00945.X
M.W. Kroon, E. Helen Kemp, B.S. Wind, G. Krebbers, J.D. Bos, D.J. Gawkrodger, A. Wolkerstorfer, J.P. Wietze van der Veen, R.M. Luiten, Melanocyte antigen-specific antibodies cannot be used as markers for recent disease activity in patients with vitiligo. Journal of The European Academy of Dermatology and Venereology. ,vol. 27, pp. 1172- 1175 ,(2013) , 10.1111/J.1468-3083.2012.04501.X
H.E. Teulings, M. Overkamp, E. Ceylan, L. Nieuweboer-Krobotova, J.D. Bos, T. Nijsten, A.W. Wolkerstorfer, R.M. Luiten, J.P.W. van der Veen, Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners British Journal of Dermatology. ,vol. 168, pp. 162- 171 ,(2013) , 10.1111/BJD.12111
PAPADOPOULOS, BOR, LEGG, HAWK, Impact of life events on the onset of vitiligo in adults: preliminary evidence for a psychological dimension in aetiology Clinical and Experimental Dermatology. ,vol. 23, pp. 243- 248 ,(1998) , 10.1046/J.1365-2230.1998.00384.X
Sibel Uncu, Savaş Yaylı, Sevgi Bahadır, Ayşenur Ökten, Köksal Alpay, Relevance of autoimmune thyroiditis in children and adolescents with vitiligo. International Journal of Dermatology. ,vol. 50, pp. 175- 179 ,(2011) , 10.1111/J.1365-4632.2010.04665.X
M. Picardo, A. Taieb, , K. Ezzedine, H. W. Lim, T. Suzuki, I. Katayama, I. Hamzavi, C. C. E. Lan, B. K. Goh, T. Anbar, C. Silva de Castro, A. Y. Lee, D. Parsad, N. van Geel, I. C. Le Poole, N. Oiso, L. Benzekri, R. Spritz, Y. Gauthier, S. K. Hann, Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference Pigment Cell & Melanoma Research. ,vol. 25, ,(2012) , 10.1111/J.1755-148X.2012.00997.X
N. van Geel, I. Mollet, L. Brochez, M. Dutré, S. De Schepper, E. Verhaeghe, J. Lambert, R. Speeckaert, New insights in segmental vitiligo: case report and review of theories British Journal of Dermatology. ,vol. 166, pp. 240- 246 ,(2012) , 10.1111/J.1365-2133.2011.10650.X